2026 NPPES data Otolaryngology Physician NPI 1679537278 M.D.
Verify on CMS →

MARK LEBEDA, M.D.

Otolaryngology Physician in EAST LANSING, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
903
Medicare Part D claims · 323 beneficiaries · Otolaryngology Physician avg: 509
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.1871/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$617.68
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK LEBEDA, M.D. reported a CMS MIPS final score of 82.1871/100 — below the 83.1 national average — and filed 903 Medicare Part D claims in 2023.

82.1871/100
MIPS score · -1 vs avg
903
Part D claims, 2023
98%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK LEBEDA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK LEBEDA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK LEBEDA, M.D.?

Near national average

NPI registry status

Active

Issued 04/12/2006

NPI 1679537278

Primary specialty

Otolaryngology Physician

Mid-sized

10,895 US NPIs in this specialty

Medicare Part D claims

903 77% vs specialty avg

2023 prescription claims

Specialty avg: 509

MIPS final score

82.1871/100 0.9128999999999934% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Michigan

How Otolaryngology Physician compares to other specialties among Michigan providers

Michigan providers

Otolaryngology Physician share within Michigan

1. Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Otolaryngology Physician share within Michigan

Medicare quality performance — MIPS

MARK LEBEDA, M.D.'s 2023 MIPS final score plotted against the Otolaryngology Physician national average

Near national average
MIPS Final Score
82.1871/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Otolaryngology Physician) — 82.1871/100 vs national avg 83.1

0%100%National avg83%82.2%
MIPS final score (Otolaryngology Physician) — 82.1871/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK LEBEDA, M.D. appears in the CMS NPPES registry as a Otolaryngology Physician provider holding M.D. credentials at 1500 ABBOT RD, EAST LANSING, MI, 48823, with a listed phone of (517) 332-0100. NPI 1679537278 was issued on 04/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LEBEDA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 903 prescription claims written by this provider, covering 323 Medicare beneficiaries and totaling roughly $33K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 2.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.1871/100 for the 2023 performance year (Quality 89.411, Cost 59.546), compared with the national average of 83.1.

Otolaryngology Physician is a mid-sized specialty nationwide, with 10,895 enrolled providers across 54 states and an average of 509 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1500 ABBOT RD
EAST LANSING, MI 48823

Provider Details

NPI 1679537278
Specialty Otolaryngology Physician
Credentials M.D.
Gender Male
NPI Issued 04/12/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.1871
Final Score
Avg: 83.1
89.411
Quality
59.546
Cost
90
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK LEBEDA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MID MICHIGAN EAR NOSE AND THROAT PC
EAST LANSING, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK LEBEDA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$618

Largest payer

Integra LifeSciences Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to MARK LEBEDA, M.D.. To verify MARK LEBEDA, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK LEBEDA, M.D. — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 903 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

903
Total Claims
$33K
Total Drug Cost
323
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,161
Total Day Supply
25,789
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$8K
Generic Drug Cost
$25K
Opioid Claims
22 (2.4% rate)
Antibiotic Claims
75

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.21
Gender Split
59% female / 41% male
Age Distribution
<65: 26, 65-74: 166, 75-84: 107, 85+: 24

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK LEBEDA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ipratropium Bromide
225
Mupirocin
72
Omeprazole
59
Fluticasone Propionate
53
Ofloxacin
48
Famotidine
46
Triamterene-Hydrochlorothiazid
Triamterene/Hydrochlorothiazid
33
Methylprednisolone
28
Doxycycline Hyclate
27
Mometasone Furoate
27

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Otolaryngology Physician Overview

How MARK LEBEDA, M.D. fits within the Otolaryngology Physician landscape nationally.

10,895
Otolaryngology Physician Providers in US
54
States with Otolaryngology Physician
509
Avg Claims per Provider

MARK LEBEDA, M.D.'s 903 claims are above the specialty average of 509.

Nearby Otolaryngology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as LEBEDA.

Compare Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK LEBEDA, M.D.'s specialty?
MARK LEBEDA, M.D. specializes in Otolaryngology Physician and practices in EAST LANSING, Michigan. Credentials: M.D..
How much does MARK LEBEDA, M.D. prescribe under Medicare Part D?
In 2023, MARK LEBEDA, M.D. wrote 903 Medicare Part D claims totaling $33K in drug costs for 323 beneficiaries.
What is MARK LEBEDA, M.D.'s Medicare quality score?
MARK LEBEDA, M.D. has a CMS MIPS Final Score of 82.1871/100 (Quality: 89.411, Cost: 59.546). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK LEBEDA, M.D. located?
MARK LEBEDA, M.D. is located at 1500 ABBOT RD, EAST LANSING, MI, 48823. Phone: (517) 332-0100.
What is MARK LEBEDA, M.D.'s NPI number?
MARK LEBEDA, M.D.'s National Provider Identifier (NPI) is 1679537278, issued on 04/12/2006.
Does MARK LEBEDA, M.D. prescribe more brand-name or generic drugs?
MARK LEBEDA, M.D.'s prescribing is 2% brand-name and 98% generic drugs by claim count, with $8K in brand drug costs.
Does MARK LEBEDA, M.D. prescribe opioids?
Yes, MARK LEBEDA, M.D. had 22 opioid claims in 2023 with an opioid prescribing rate of 2.4%.
How many Otolaryngology Physician providers are there in the US?
There are 10,895 Otolaryngology Physician providers across 54 states in the US. The average Otolaryngology Physician provider writes 509 Medicare Part D claims per year.
What drugs does MARK LEBEDA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK LEBEDA, M.D.'s most frequently prescribed drugs include Ipratropium Bromide, Mupirocin, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK LEBEDA, M.D. accept Medicare?
MARK LEBEDA, M.D. appears in CMS Medicare data with 903 Part D claims and 323 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK LEBEDA, M.D.'s credentials?
MARK LEBEDA, M.D.'s NPI is 1679537278 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology